MedPath

Effectiveness of Dance on Patients With Fibromyalgia

Not Applicable
Completed
Conditions
Fibromyalgia
Registration Number
NCT00961805
Lead Sponsor
Federal University of São Paulo
Brief Summary

The aim of the present study is to assess the effectiveness of belly dance as a treatment for pain and improving the quality of life of patients with fibromyalgia.

Eighty female patients with fibromyalgia between 18 to 65 years were randomly allocated to a dance group (n=40) and control group (n=40). Patients in the dance group underwent 16 weeks of belly dance twice a week, while the patients in the control group remained on a waiting list. Patients were evaluated with regard to pain (Visual Analogue Scale), function (6 minute walk test), quality of life (Fibromyalgia Impact Questionnaire and SF-36), depression (Beck Inventory), anxiety (State-Trait Anxiety Inventory) and self-image (Body Dysmorphic Disorder Examination) questionnaire. Evaluations were carried out at baseline, after 16 weeks and after 32 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • classification of fibromyalgia based on the criteria of the American College of Rheumatology
  • female gender
  • aged between 18 and 65 years
Exclusion Criteria
  • not having altered treatment in previous three years
  • having signed a term of informed consent
  • patients with other rheumatic diseases, painful osteoarticular conditions, uncontrolled cardiopulmonary disease, diseases of the lower limbs or uncontrolled diabetes were excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale for Painbaseline, after 16 weeks and after 32 weeks

score between 0 and 100 where 0 is no pain and 100 in unbearable pain

Secondary Outcome Measures
NameTimeMethod
Quality of Life - SF-36 - Emotional Aspectsbaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Function - 6 Minute Walk Testbaseline, after 16 weeks and after 32 weeks

meters traveled on a 20-meter course over a six-minute period

Quality of Life - Fibromyalgia Impact Questionnairebaseline, after 16 weeks and after 32 weeks

score between 0 from 10 with 0 indicating no impairment and 10 indicating maximum impairment

Quality of Life - SF-36 -Functional Capacitybaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Quality of Life - SF-36 - Physical Limitationbaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Quality of Life - Sf-36 - Painbaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Quality of Life - Sf-36 - General Health Statebaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Quality of Life - SF-36 - Vitalitybaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Quality of Life - SF-36 - Social Aspectsbaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Quality of Life - SF-36 - Mental Healthbaseline, after 16 weeks and after 32 weeks

score between 0 from 100, with higher scores denoting better quality of life

Depression - Beck InventoryBaseline, after 16 weeks and after 32 weeks

score between 0 from 63, with higher score indicating greater depression

Self-image - Body Dysmorphic Disorder Examination QuestionnaireBaseline, after 16 weeks and after 32 weeks

scored between 0 from 168, with higher scores indicating greater level of dissatisfaction with self-image

Trial Locations

Locations (1)

Federal University of Sao Paulo

🇧🇷

Sao Paulo, SP, Brazil

Federal University of Sao Paulo
🇧🇷Sao Paulo, SP, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.